Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial...

Area of Science:

• Hepatology
• Cancer Biology
• Immunology

Background:

• Intrahepatic cholangiocarcinoma (ICC) is an aggressive liver cancer with limited therapeutic options.
• Mitochondrial dysfunction and oxidative stress are implicated in cancer development.
• Kupffer cells play a role in liver inflammation and immune responses.

Purpose of the Study:

• To investigate the role of mitochondrial dysfunction, oxidative stress, and Kupffer cells in ICC development.
• To identify key molecular pathways driving ICC tumorigenesis.
• To explore potential therapeutic targets for ICC.

Main Methods:

• Utilized mouse models of ICC with genetic modifications (e.g., JNK1/2 deletion) and pharmacological interventions (anti-oxidants, Kupffer cell depletion).
• Assessed pre-neoplastic lesions, tumor development, and survival rates.
• Analyzed human ICC tissues for Tnf expression, JNK phosphorylation, and ROS accumulation.

Main Results:

• Mitochondrial dysfunction and reactive oxygen species (ROS) from liver damage create a pro-tumorigenic niche.
• Kupffer cell-derived tumor necrosis factor (Tnf) promotes JNK-mediated cholangiocellular proliferation.
• Inhibition of ROS, Tnf, or JNK signaling reduced pre-neoplastic lesions and tumor growth.
• Targeting the ROS/Tnf/JNK axis improved survival in ICC models.

Conclusions:

• Kupffer cell-derived Tnf is a critical driver of ICC proliferation and carcinogenesis.
• The ROS/Tnf/JNK signaling axis represents a promising therapeutic target for intrahepatic cholangiocarcinoma.
• Modulating this pathway may offer new treatment strategies for patients with ICC.